England to ban single-use e-cigarettes from June 2025

Oct.24.2024
England to ban single-use e-cigarettes from June 2025
The UK government has announced that England will ban the sale of single-use e-cigarettes from 1 June 2025. On the 22nd of this month, the Welsh Government also issued a statement on its official website confirming a ban on the use of disposable e-cigarettes from June 2025. Currently, two of the four UK regions have issued official statements on the matter.

The UK government announced on its official website on 24th October that England will ban the sale of single-use e-cigarettes from 1 June 2025.

 

Minister for the Circular Economy Mary Creagh confirmed today (24 October) that a new bill has been introduced to Parliament to ban the sale of single-use e-cigarettes from 1 June 2025.

 

The UK government has introduced legislation to ban the sale of remaining stocks by businesses by 1 June 2025, subject to parliamentary approval. Businesses will need to prepare for the ban to take effect. The UK Cabinet Office and local authorities are working closely together to set a consistent date.

 

Between 2012 and 2023, the use of e-cigarettes in England is expected to increase by over 400%, with 9.1% of the UK population currently buying and using these products.

 

Minister for the Circular Economy Mary Creagh said: "Single-use e-cigarettes are extremely wasteful and have caused concern in our towns and cities."

 

"That's why we need to ban single-use e-cigarettes to end the culture of waste in this country," she said. "This is the first step towards a circular economy, where we will extend the use of resources, reduce waste, accelerate progress towards net zero emissions and create thousands of job opportunities across the country."

 

Minister for Public Health and Prevention Andrew Gwynne added: "It is worrying that a quarter of 11-15 year olds used e-cigarettes last year, with disposable e-cigarettes being the choice of most children. Banning disposable e-cigarettes will not only help protect the environment, it will also reduce the appeal of e-cigarettes to children and prevent vulnerable young people from being influenced. The Government will also implement the Tobacco and Electronic Cigarettes Act, the most important public health measure for generations, to protect young people from the effects of nicotine and pave the way for a smoke-free Britain."

 

Green Alliance's Head of Resources, Libby Peake, said: "single-use e-cigarettes are the last thing our children and the planet need, and the unchecked growth of the market for them has gone on for far too long. Each one is a waste of vital resources needed for more sustainable economic development, such as the lithium used in electric vehicle batteries. When littered, the nicotine, plastics and batteries they contain are extremely harmful. Even if thrown away, their batteries can catch fire. Government bans on these harmful devices are a welcome step towards reducing waste in the economy."

 

"The emergence of single-use e-cigarettes, possibly the first mainstream disposable electronic device, is polluting our streets and reflects the continued evolution of the tobacco industry. The UK government's plan to ban these disposable products by 2025 is a popular and important step. The ban not only aims to reduce the number of discarded e-cigarettes, but also challenges the wider trend of disposable technology, which is contributing to a worrying increase in electronic waste, accompanied by fire hazards and the use of scarce materials. From a health perspective, I also welcome this ban and believe it is essential in breaking the control of e-cigarettes over young people and challenging the throwaway culture that threatens to choke our planet," said climate campaigner and environmental scientist, Less Waste Laura.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
Imperial Brands Sees Double-Digit NGP Growth as Sixth Year of Tobacco Revenue Gains Backs £1.5 Billion Buyback
Imperial Brands Sees Double-Digit NGP Growth as Sixth Year of Tobacco Revenue Gains Backs £1.5 Billion Buyback
Imperial Brands reaffirmed its FY26 guidance in its October 8 pre-close trading update, forecasting double-digit net revenue growth in next-generation products and share gains across heated tobacco, vape and modern oral. Tobacco net revenue is expected to grow at a low-single-digit rate, marking a sixth consecutive year of growth. The company has completed its £1.45 billion FY26 share repurchase and announced a £1.5 billion buyback for FY27. Group adjusted operating profit is expected to increase 3% to 5%, while free cash flow is forecast to exceed £2.2 billion.
Oct.09
South Korea Imports 12,126 Kg of Nicotine Analogues From April to August After Bringing Synthetic Nicotine Under Tobacco Law
South Korea Imports 12,126 Kg of Nicotine Analogues From April to August After Bringing Synthetic Nicotine Under Tobacco Law
South Korea's liquid-vape market is showing changes across raw-material imports, product types and sales channels after synthetic nicotine came under the Tobacco Business Act on April 24. Customs data show nicotine-analogue imports totaled 12,126 kilograms from April through August, while synthetic-nicotine imports over the same five months totaled 231,663 kilograms, just 39.3% of the amount imported in March alone. Physical liquid-vape stores tracked in Seoul and Gyeonggi Province fell 9.9%, unmanned outlets edged higher and online sales listings increased from 27,774 to 42,437. Government testing of 105 liquid inhalation products promoted as nicotine-free separately found nicotine in 13 and 6-methylnicotine in 12.
Sep.22
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
At the 2026 NACS Show in Las Vegas, Philip Morris International (PMI) showcased its ZYN nicotine pouches, IQOS heated tobacco products and U.S. investments. A 2Firsts review of FDA records found that several ZYN products displayed at the booth were not on the agency's marketing authorization list, including certain nicotine strengths and flavors. A PMI booth representative also confirmed that IQOS is currently sold in three U.S. states, while the newer IQOS ILUMA system remains under FDA review.
EXPO
Oct.10
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India's Ministry of Health and Family Welfare has directed states to step up enforcement against nicotine pouch sales, citing increased availability through online and offline channels and concern about nicotine exposure among children. Reuters reported that international brands including ZYN and White Fox are being sold in India. A study led by ICMR-NICPR found pouches in seven of 10 surveyed locations and identified 68 brands and 445 flavors online. Separately, India's Drugs Technical Advisory Board recommended in August that no new nicotine formulation be approved.
Regulations
Sep.28 by 2Firsts Perspectives
India Duty-Free Nicotine Pouch Sales Face Regulatory Test as ZYN, FOX Classification Remains Open
India Duty-Free Nicotine Pouch Sales Face Regulatory Test as ZYN, FOX Classification Remains Open
The Bombay High Court has ruled that airport duty-free shops are not exempt from India's domestic regulatory laws merely because they operate beyond the customs barrier, leaving in place a sales halt covering ZYN and FOX nicotine pouches at Mumbai's international airport. The court, however, did not determine that the products necessarily qualify as "drugs" under India's Drugs and Cosmetics Act. The retailers have four weeks to submit product information to the appropriate authorities, including CDSCO, which must complete its review within 30 days of receiving the submissions.
Sep.24